注射用红花黄色素联合阿加曲班治疗急性脑梗死的临床研究
本文选题:注射用红花黄色素 切入点:阿加曲班注射液 出处:《现代药物与临床》2016年02期
【摘要】:目的探讨注射用红花黄色素联合阿加曲班治疗急性脑梗死的临床疗效。方法选取2014年9月—2015年9月西安医学院第二附属医院收治的急性脑梗死患者96例,依据不同治疗方案分为治疗组和对照组,每组各48例。所有患者均给予降低颅内压、营养神经、调节血脂等基础治疗。对照组在此基础上给予阿加曲班注射液,第1~2天,阿加曲班注射液60mg加入生理盐水500 m L,24 h持续泵入;其后5 d,阿加曲班注射液10 mg加入生理盐水100 m L,3 h持续泵入,2次/d,第8~14天,1次/d。治疗组在对照组的基础上滴注注射用红花黄色素,100 m L/次,1次/d。两组均连续治疗2周。观察两组临床疗效,同时比较两组神经功能缺损量表(NIHSS)评分、Barthel指数、血液流变学指标和血管内皮功能及炎症因子变化情况。结果治疗后,对照组和治疗组总有效率分别为77.08%、91.67%,两组比较差异有统计学意义(P0.05)。治疗后,两组血浆黏度、全血黏度、红细胞压积(HCT)以及红细胞聚集指数(RF)均显著降低,同组治疗前后比较差异具有统计学意义(P0.05);且治疗后治疗组这些观察指标显著低于对照组,两组比较差异具有统计学意义(P0.05)。治疗后,两组NIHSS评分均降低,Barthel指数均升高,同组治疗前后比较差异具有统计学意义(P0.05);且治疗2周后治疗组这些观察指标显著好于对照组,两组比较差异具有统计学意义(P0.05)。治疗后,两组一氧化氮(NO)、内皮素-1(ET-1)、白细胞介素-8(IL-8)和肿瘤坏死因子α(TNF-α)表达水平均较治疗前明显改善,同组治疗前后比较差异具有统计学意义(P0.05);且治疗2周后治疗组这些观察指标显著好于对照组,两组比较差异具有统计学意义(P0.05)。结论注射用红花黄色素联合阿加曲班治疗急性脑梗死具有较好的临床疗效,能明显改善患者的血液流变学指标和血管内皮功能,具有一定的临床推广应用价值。
[Abstract]:Objective to investigate the clinical effect of safflower yellow pigment combined with agaltreban for injection in the treatment of acute cerebral infarction.Methods 96 patients with acute cerebral infarction treated in the second affiliated Hospital of Xi'an Medical College from September 2014 to September 2015 were divided into treatment group (n = 48) and control group (n = 48).All patients were treated with basic treatment such as reducing intracranial pressure, nourishing nerves and regulating blood lipids.The control group was given Agatripine injection on this basis. On the 1st day of 2 days, 60mg was continuously pumped into the control group for 24 h with normal saline (500m L / L).After 5 days, 10 mg of agatoban injection was injected with 100 mL normal saline for 3 h and pumped continuously for 2 times per day, and once per day on day 814.On the basis of the control group, the treatment group was injected with safflower yellow pigment 100 mL / once a day.The two groups were treated continuously for 2 weeks.The clinical efficacy of the two groups was observed, and the changes of Barthel index, hemorheology index, vascular endothelial function and inflammatory factors were compared between the two groups.Results after treatment, the total effective rates of the control group and the treatment group were 77.08 and 91.67, respectively. The difference between the two groups was statistically significant (P 0.05).After treatment, plasma viscosity, whole blood viscosity, hematocrit HCT (HCT) and erythrocyte aggregation index (RFRF) of the two groups were significantly lower than those of the control group, and the difference between the two groups before and after treatment was statistically significant (P 0.05), and after treatment these indexes in the treatment group were significantly lower than those in the control group.The difference between the two groups was statistically significant (P 0.05).After treatment, the NIHSS scores of the two groups were significantly lower than those of the control group, and the difference between the two groups before and after treatment was statistically significant (P 0.05), and after 2 weeks of treatment, these indexes in the treatment group were significantly better than those in the control group, and the difference between the two groups was statistically significant.After treatment, the expression levels of nitric oxide, endothelin-1, interleukin-8 (IL-8) and tumor necrosis factor 伪 (TNF- 伪) in both groups were significantly improved compared with those before treatment.The difference before and after treatment in the same group was statistically significant (P 0.05), and the observation index in the treatment group was significantly better than that in the control group after 2 weeks of treatment, and the difference between the two groups was statistically significant (P 0.05).Conclusion the combination of safflower yellow and agatoban for injection has a good clinical effect on acute cerebral infarction. It can obviously improve the hemorheological index and vascular endothelial function of the patients, and has a certain clinical application value.
【作者单位】: 西安医学院第二附属医院神经内科;
【分类号】:R743.3
【相似文献】
相关期刊论文 前10条
1 沈庆煜;肖颂华;叶剑虹;杨炼红;;阿加曲班治疗椎基底动脉供血不足的疗效观察[J];岭南急诊医学杂志;2007年01期
2 许俊堂;;阿加曲班临床应用的进展[J];血栓与止血学;2007年04期
3 罗承锋;;阿加曲班的药理作用与临床应用[J];血栓与止血学;2007年04期
4 张子彦;张宏卫;;阿加曲班研究进展[J];国际内科学杂志;2007年08期
5 郭大庆;秦群;戴智勇;龙靓;肖宇航;闵慧;严娟;;人血浆中阿加曲班浓度测定的方法学研究[J];中南药学;2009年03期
6 王运红;欧阳晨曦;周玫;金毕;赖传善;;阿加曲班的临床应用及临床监测方法[J];中华临床医师杂志(电子版);2010年04期
7 ;阿加曲班治疗急性缺血性脑卒中的应用建议[J];中华老年心脑血管病杂志;2010年09期
8 赵秀欣;张微微;魏亚洲;;阿加曲班治疗急性缺血性脑卒中的临床研究[J];中华老年心脑血管病杂志;2010年09期
9 赵智江;张微微;赵秀欣;范慧敏;刘楠;;阿加曲班治疗急性缺血性脑卒中疗效及应用时机的临床研究[J];中华老年心脑血管病杂志;2012年02期
10 张艳秋;邵义泽;;阿加曲班治疗短暂性脑缺血发作的临床疗效观察[J];实用心脑肺血管病杂志;2013年12期
相关会议论文 前3条
1 高山;程焱;;凝血酶抑制剂阿加曲班对脑出血后灶周组织的影响[A];第十一届全国神经病学学术会议论文汇编[C];2008年
2 胡会社;马庆久;王崇宝;;阿加曲班在肝素诱发血小板减少症的应用[A];中华中医药学会周围血管病分会第四届学术大会暨中华中医药学会周围血管病分会25年会庆论文集[C];2011年
3 邵秀茹;李家增;孙明艳;陈波;贡铁军;陈德发;吴宏菊;关小军;马军;;阿加曲班治疗急性早幼粒细胞白血病合并DIC的临床研究[A];第10届全国实验血液学会议论文摘要汇编[C];2005年
相关重要报纸文章 前1条
1 马克;直接凝血酶抑制剂——阿加曲班[N];中国医药报;2005年
相关博士学位论文 前2条
1 高山;凝血酶抑制剂阿加曲班对实验性大鼠脑出血灶周组织作用的研究[D];天津医科大学;2008年
2 谢祥;去铁胺和阿加曲班减轻非张力性血肿对扩张皮瓣影响的实验研究[D];中国协和医科大学;2008年
相关硕士学位论文 前10条
1 侯志冰;阿加曲班抑制兔颈总静脉移植术后再狭窄作用的研究[D];福建医科大学;2015年
2 赵智江;阿加曲班治疗急性缺血性脑卒中疗效及应用时机的临床研究[D];山西医科大学;2012年
3 朱晓冬;国产阿加曲班注射液治疗急性脑梗塞有效性及安全性的临床研究[D];天津医科大学;2004年
4 周鼎;抗凝药阿加曲班的合成方法研究[D];河北医科大学;2013年
5 李静;阿加曲班对急性脑梗死患者血小板功能的影响研究[D];山西医科大学;2011年
6 孔燕;阿加曲班治疗急性缺血性卒中的系统评价[D];广西医科大学;2011年
7 周露露;阿加曲班对脑血管支架置入术后再狭窄及临床事件影响的随机对照研究[D];南方医科大学;2013年
8 王刚;阿加曲班原料药中的杂质控制[D];浙江大学;2014年
9 李志平;阿加曲班改性聚醚砜膜的构建及其抗凝性能检测[D];中南大学;2013年
10 赵倩影;阿加曲班治疗进展性脑梗死的临床观察[D];大连医科大学;2014年
,本文编号:1698759
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/1698759.html